Enzon Pharmaceuticals, INC. (ENZN) SEC Filings — 2025

Filings

• Enzon Pharmaceuticals, INC. 8-K Filing — 8-K · Dec 23, 2025
• Enzon's Losses Mount Amid Zero Revenue, Viskase Merger Costs — 10-Q · Nov 12, 2025
• Enzon Pharmaceuticals Files 8-K for Material Agreement — 8-K · Oct 24, 2025
• Enzon Pharmaceuticals Files 8-K: Material Agreement & Security Holder Updates — 8-K · Sep 30, 2025
• Enzon's Q2 Losses Mount Amid Zero Revenue, Viskase Merger Costs — 10-Q · Aug 14, 2025
• Enzon Pharmaceuticals Files 8-K: Material Agreement — 8-K · Jun 23, 2025
• Enzon Pharmaceuticals Files Q1 2025 10-Q — 10-Q · May 9, 2025
• Enzon Pharmaceuticals Files 10-K/A Amendment for Part III Info — 10-K/A · Apr 28, 2025
• Enzon Pharmaceuticals Files 8-K: Material Agreement & More — 8-K · Apr 1, 2025
• Enzon Pharmaceuticals Files 2024 Annual Report — 10-K · Feb 21, 2025
• Enzon Pharmaceuticals CFO Departs, New CFO Appointed — 8-K · Jan 10, 2025